M28 Capital Management LP Q4 2024 Filing
Filed February 13, 2025
Portfolio Value
$101.9B
Holdings
11
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (11 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | WVEWAVE LIFE SCIENCES LTD | 5,664,548 | $70.1B | 68.79% | |
| 2 | TGTXTG THERAPEUTICS INC | 161,600 | $4.9B | 4.78% | |
| 3 | RCKTROCKET PHARMACEUTICALS INC | 385,680 | $4.8B | 4.76% | |
| 4 | IVVDINVIVYD INC | 9,248,250 | $4.1B | 4.02% | |
| 5 | SWTXSPRINGWORKS THERAPEUTICS INC | 110,400 | $4.0B | 3.92% | |
| 6 | GUTSFRACTYL HEALTH INC | 1,856,117 | $3.8B | 3.75% | |
| 7 | BBIOBRIDGEBIO PHARMA INC | 121,200 | $3.3B | 3.27% | |
| 8 | PRQRPROQR THRAPEUTICS N V | 1,019,498 | $2.7B | 2.65% | |
| 9 | CRISCURIS INC | 521,059 | $1.6B | 1.57% | |
| 10 | SLNSILENCE THERAPEUTICS PLC | 185,100 | $1.3B | 1.25% | |
| 11 | ARWRARROWHEAD PHARMACEUTICALS IN | 67,400 | $1.3B | 1.24% |